Tandem Diabetes Care, Inc.
Symbool: TNDM
NASDAQ
35.24
USDMarktprijs vandaag
-10.3481
Koers/Winst Verhouding
-0.1231
Koers/Winst Groei Verhouding
2.28B
MRK Kapitalisatie
- 0.00%
DIV Rendement
Tandem Diabetes Care, Inc. (TNDM) Jaarrekeningen
Balans
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 1992.9 | 467.9 | 616.9 | 623.8 | |||||||||||||
balance-sheet.row.short-term-investments | 1595.91 | 409 | 444.4 | 552.6 | |||||||||||||
balance-sheet.row.net-receivables | 395.98 | 105.6 | 114.7 | 110.7 | |||||||||||||
balance-sheet.row.inventory | 580.59 | 157.9 | 111.1 | 68.6 | |||||||||||||
balance-sheet.row.other-current-assets | 58.89 | 16.6 | 7.2 | 8.4 | |||||||||||||
balance-sheet.row.total-current-assets | 3028.36 | 748 | 850 | 811.5 | |||||||||||||
balance-sheet.row.property-plant-equipment-net | 673.65 | 164.3 | 179.2 | 77.9 | |||||||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | |||||||||||||
balance-sheet.row.intangible-assets | 2.78 | 2.8 | 4.6 | 6.6 | |||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 2.78 | 2.8 | 4.6 | 6.6 | |||||||||||||
balance-sheet.row.long-term-investments | 20.2 | 10.1 | 8.3 | 0 | |||||||||||||
balance-sheet.row.tax-assets | -10.1 | -10.1 | -8.3 | 0 | |||||||||||||
balance-sheet.row.other-non-current-assets | 78.5 | 37.6 | 19 | 9.1 | |||||||||||||
balance-sheet.row.total-non-current-assets | 765.03 | 204.7 | 202.8 | 93.6 | |||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||
balance-sheet.row.total-assets | 3793.39 | 952.7 | 1052.8 | 905.1 | |||||||||||||
balance-sheet.row.account-payables | 208.04 | 49.6 | 55.7 | 28 | |||||||||||||
balance-sheet.row.short-term-debt | 68.28 | 17.1 | 13.1 | 9.3 | |||||||||||||
balance-sheet.row.tax-payables | 0 | 0 | 0 | 0 | |||||||||||||
balance-sheet.row.long-term-debt-total | 1606.27 | 398.6 | 406.8 | 305.4 | |||||||||||||
Deferred Revenue Non Current | 58.61 | 13.3 | 16.9 | 16.9 | |||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||||||||||
balance-sheet.row.other-current-liab | 332.09 | 84.6 | 77.6 | 84.4 | |||||||||||||
balance-sheet.row.total-non-current-liabilities | 1769.59 | 443.8 | 447.5 | 340.2 | |||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||
balance-sheet.row.capital-lease-obligations | 537.13 | 130.6 | 136.6 | 33.2 | |||||||||||||
balance-sheet.row.total-liab | 2497.77 | 639 | 612.8 | 472 | |||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||||||
balance-sheet.row.common-stock | 0.26 | 0.1 | 0.1 | 0.1 | |||||||||||||
balance-sheet.row.retained-earnings | -3615.5 | -951.8 | -729.2 | -634.6 | |||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | -2.12 | 1.4 | -1.8 | -0.6 | |||||||||||||
balance-sheet.row.other-total-stockholders-equity | 4912.98 | 1264 | 1170.9 | 1068.3 | |||||||||||||
balance-sheet.row.total-stockholders-equity | 1295.62 | 313.6 | 439.9 | 433.1 | |||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 3793.39 | 952.7 | 1052.8 | 905.1 | |||||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | |||||||||||||
balance-sheet.row.total-equity | 1295.62 | 313.6 | 439.9 | 433.1 | |||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 3793.39 | - | - | - | |||||||||||||
Total Investments | 1595.91 | 409 | 444.4 | 552.6 | |||||||||||||
balance-sheet.row.total-debt | 1674.56 | 415.7 | 419.9 | 314.7 | |||||||||||||
balance-sheet.row.net-debt | 1277.57 | 356.8 | 247.4 | 243.5 |
Kasstroomoverzicht
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | -222.61 | -222.6 | -94.6 | 15.6 | |||||||||||||
cash-flows.row.depreciation-and-amortization | 15.71 | 15.7 | 14.3 | 13.8 | |||||||||||||
cash-flows.row.deferred-income-tax | 0 | 9.1 | 0 | 4.6 | |||||||||||||
cash-flows.row.stock-based-compensation | 88.08 | 88.1 | 84.9 | 60.8 | |||||||||||||
cash-flows.row.change-in-working-capital | -17.68 | -17.7 | -4.6 | 14.4 | |||||||||||||
cash-flows.row.account-receivables | 4.28 | 4.3 | -7.8 | -31 | |||||||||||||
cash-flows.row.inventory | -46.05 | -46.1 | -42.5 | -5 | |||||||||||||
cash-flows.row.account-payables | -4.86 | -4.9 | 24.5 | 10.3 | |||||||||||||
cash-flows.row.other-working-capital | 28.95 | 29 | 21.1 | 40 | |||||||||||||
cash-flows.row.other-non-cash-items | 104.69 | 95.6 | 50.5 | 2.3 | |||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | -31.81 | 0 | 0 | 0 | |||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -51.6 | -51.6 | -43 | -23.5 | |||||||||||||
cash-flows.row.acquisitions-net | -69.5 | -69.5 | -25.7 | 9.3 | |||||||||||||
cash-flows.row.purchases-of-investments | -510.86 | -510.9 | -467.7 | -733.4 | |||||||||||||
cash-flows.row.sales-maturities-of-investments | 546.22 | 546.2 | 569.5 | 570 | |||||||||||||
cash-flows.row.other-investing-activites | 65.07 | 0 | 0 | -9.3 | |||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -85.74 | -85.7 | 33.2 | -186.9 | |||||||||||||
cash-flows.row.debt-repayment | 0 | 0 | 0 | 0 | |||||||||||||
cash-flows.row.common-stock-issued | 6.29 | 4.2 | 17.5 | 51.3 | |||||||||||||
cash-flows.row.common-stock-repurchased | -0.54 | 0 | 0 | 0 | |||||||||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | |||||||||||||
cash-flows.row.other-financing-activites | 2.31 | -0.1 | -0.6 | 0.6 | |||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 4.11 | 4.1 | 16.9 | 51.9 | |||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | -0.21 | -0.2 | 0.8 | 0.2 | |||||||||||||
cash-flows.row.net-change-in-cash | -113.65 | -113.6 | 101.3 | -23.4 | |||||||||||||
cash-flows.row.cash-at-end-of-period | 396.99 | 58.9 | 172.5 | 71.2 | |||||||||||||
cash-flows.row.cash-at-beginning-of-period | 510.64 | 172.5 | 71.2 | 94.6 | |||||||||||||
cash-flows.row.operating-cash-flow | -31.81 | -31.8 | 50.5 | 111.4 | |||||||||||||
cash-flows.row.capital-expenditure | -51.6 | -51.6 | -43 | -23.5 | |||||||||||||
cash-flows.row.free-cash-flow | -83.41 | -83.4 | 7.5 | 87.8 |
Rij winst-en-verliesrekening
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 747.72 | 747.7 | 801.2 | 702.8 | |||||||||||||
income-statement-row.row.cost-of-revenue | 380.03 | 380 | 388.2 | 326.6 | |||||||||||||
income-statement-row.row.gross-profit | 367.69 | 367.7 | 413 | 376.2 | |||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||
income-statement-row.row.research-development | 169.67 | - | - | - | |||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||
income-statement-row.row.other-expenses | 83.8 | 78.8 | 0 | 0 | |||||||||||||
income-statement-row.row.operating-expenses | 522.17 | 522.2 | 474.8 | 353.6 | |||||||||||||
income-statement-row.row.cost-and-expenses | 902.2 | 902.2 | 863 | 680.1 | |||||||||||||
income-statement-row.row.interest-income | 22.86 | 22.9 | 6.1 | 0.7 | |||||||||||||
income-statement-row.row.interest-expense | -3.67 | 7.6 | 4.3 | 4.3 | |||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||
income-statement-row.row.total-other-income-expensenet | 12.98 | -78.8 | -31 | 7.1 | |||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||
income-statement-row.row.other-operating-expenses | 83.8 | 78.8 | 0 | 0 | |||||||||||||
income-statement-row.row.total-operating-expenses | 12.98 | -78.8 | -31 | 7.1 | |||||||||||||
income-statement-row.row.interest-expense | -3.67 | 7.6 | 4.3 | 4.3 | |||||||||||||
income-statement-row.row.depreciation-and-amortization | 88.47 | 15.7 | 31 | 13.8 | |||||||||||||
income-statement-row.row.ebitda-caps | -56.7 | - | - | - | |||||||||||||
income-statement-row.row.operating-income | -151.88 | -233.2 | -61.8 | 8.8 | |||||||||||||
income-statement-row.row.income-before-tax | -220.25 | -220.3 | -92.9 | 15.9 | |||||||||||||
income-statement-row.row.income-tax-expense | 2.36 | 2.4 | 1.7 | 0.3 | |||||||||||||
income-statement-row.row.net-income | -222.61 | -222.6 | -94.6 | 15.6 |
Vaak gestelde vragen
Wat is Tandem Diabetes Care, Inc. (TNDM) totale activa?
Tandem Diabetes Care, Inc. (TNDM) totale activa is 952658000.000.
Wat is de jaarlijkse omzet van de onderneming?
De jaarlijkse omzet is 382418000.000.
Wat is de winstmarge van de onderneming?
De bedrijfswinstmarge is 0.492.
Wat is vrije kasstroom van de onderneming?
De vrije kasstroom is {free_cash_flow}}.
Wat is de nettowinstmarge van de onderneming?
De nettowinstmarge is -0.298.
Wat is de totale omzet van de onderneming?
De totale opbrengst is -0.203.
Wat is Tandem Diabetes Care, Inc. (TNDM) nettowinst (netto-inkomen)?
De nettowinst is -222611000.000.
Wat is de totale schuld van het bedrijf?
De totale schuld is 415667000.000.
Wat zijn de bedrijfskosten?
De bedrijfsuitgaven zijn 522170000.000.
Wat is het kasstroomcijfer van het bedrijf?
Enretprise cash is 58868000.000.